Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY:MCK)

816.06 +1.43 (+0.18%)
Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >
News headline image
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug ↗
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy... 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About McKesson ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About McKesson? ↗
 
Via Benzinga
News headline image
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks ↗
New growth drivers are helping to propel these reliable and steady businesses. 
Via The Motley Fool
News headline image
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗
 
Via Benzinga
News headline image
(MCK) - Analyzing McKesson's Short Interest ↗
 
Via Benzinga
News headline image
Peering Into McKesson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode. 
Via InvestorPlace
McKesson Corp. (NYSE: MCK) Sets New 52-Week High in Friday Session
Via Investor Brand Network
Topics Economy
News headline image
Analyst Ratings for McKesson ↗
 
Via Benzinga
News headline image
McKesson Unusual Options Activity For November 01 ↗
 
Via Benzinga
News headline image
A Preview Of McKesson's Earnings ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed lower by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
3 Evergreen Stocks for Long-term Wealth Generation ↗
Finding solid long-term stocks that aren't value traps is tough, but these stocks have great fundamentals and equally compelling prospects. 
Via InvestorPlace
News headline image
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review ↗
Bulls are back in control as the major indexes confirmed the uptrend this week. 
Via Investor's Business Daily
News headline image
Peering Into McKesson's Recent Short Interest ↗
 
Via Benzinga
News headline image
McKesson (MCK) Q2 2024 Earnings Call Transcript ↗
MCK earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
From McKesson Corporation
Via Business Wire
News headline image
Top 3 Blue-Chip Stocks in the Healthcare Industry ↗
These are some of the best healthcare blue-chip stocks by market capitalization, offering great returns for investors. 
Via InvestorPlace
News headline image
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals ↗
McKesson earnings are on tap, with Cencora and Cardinal Health due soon. 
Via Investor's Business Daily
News headline image
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision ↗
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely... 
Via Benzinga
Topics Economy
News headline image
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday ↗
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
News headline image
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500! ↗
Amidst the S&P 500's 7% decline since July, McKesson Corp's stock has notably risen by 12%. McKesson has experienced a rise since December 2018 of 347%. McKesson's Q2 earnings estimate stands at... 
Via Benzinga
Topics Stocks
News headline image
7 Healthcare Stocks That Can Cure a Lackluster Portfolio ↗
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.